Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zota Health CareNSE:ZOTA -8.86%78 5-Year Yield-on-Cost % is 0.08 as of Aug. 16, 2026, which is 71% below its 10-year median of 0.28. GuruFocus rates NSE:ZOTA with a GF Score™ of 78/100 and a GF Value™ of ₹1,693.41 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 150 Biotechnology companies, Zota Health Care ranks worse than 98% on this metric.
Zota Health Care's yield on cost for the quarter that ended in Mar. 2026 was 0.08.
The historical rank and industry rank for Zota Health Care's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:ZOTA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.06 Med: 0.28 Max: 0.72
Current: 0.08
During the past 13 years, Zota Health Care's highest Yield on Cost was 0.72. The lowest was 0.06. And the median was 0.28.
NSE:ZOTA's 5-Year Yield-on-Cost % is ranked worse than 98% of 150
companies
in the Biotechnology industry
Industry Median: 1.61
vs NSE:ZOTA: 0.08
Zota Health Care (NSE:ZOTA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Zota Health Care 5-Year Yield-on-Cost % Related Terms
NSE:ZOTA vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Zota Health Care's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zota Health Care 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zota Health Care's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Zota Health Care's 5-Year Yield-on-Cost % falls into.
Zota Health Care 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Zota Health Care (NSE:ZOTA) has a 5-Year Yield-on-Cost % of 0.08 as of Aug. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zota Health Care and its competitors. This is 71% below median its historical median of 0.28. Over the past decade, Zota Health Care's 5-Year Yield-on-Cost % has ranged from 0.06 to 0.72. According to the industry distribution chart, Zota Health Care ranks #147 out of 150 companies in the Biotechnology industry, placing it in the top 98%.
Is Zota Health Care's 5-Year Yield-on-Cost % too high?
Zota Health Care's current 5-Year Yield-on-Cost % of 0.08 is 71% below median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.72. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.61. Zota Health Care's value of 0.08 is 95% below this industry median. Based on the distribution chart, Zota Health Care ranks #147 out of 150 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zota Health Care has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zota Health Care ranks #147 out of 150 companies for 5-Year Yield-on-Cost %. This places Zota Health Care in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.61. Zota Health Care's value of 0.08 is 95% below this benchmark. Historically, Zota Health Care's own 5-Year Yield-on-Cost % has ranged from 0.06 to 0.72 over the past decade. While the company's 10-year median is 0.28 vs. the industry median of 1.61, Zota Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.61, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zota Health Care's current 5-Year Yield-on-Cost % of 0.08 is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zota Health Care and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zota Health Care's current 5-Year Yield-on-Cost % is 0.08, which is 71% below median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,693.41, compared to a current price of ₹1,131.30 — trading 33.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.08, which is 71% below median its 10-year median of 0.28 and 95% below the Biotechnology industry median of 1.61. Zota Health Care's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current 5-Year Yield-on-Cost % is 0.08 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?
Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued.
The current stock price of ₹1,131.30 is trading 33.2% below its estimated GF Value™ of ₹1,693.41.
GuruFocus considers Zota Health Care to be Possible Value Trap.
Key valuation signals for NSE:ZOTA:
5-Year Yield-on-Cost %: 0.08 (71% below median its 10-year median of 0.28)
GF Value™: ₹1,693.41 vs. price of ₹1,131.30 (33.2% below fair value)
Industry Position: 95% below the Biotechnology median (#147 of 150)
No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
78GF Score
Get the complete analysis for NSE:ZOTA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZOTA has been successfully added to your 
